Established Pharmaceuticals — Goodwill, non-deductible
Abbott Established Pharmaceuticals — Goodwill, non-deductible remained flat by 0.0% to $2.70B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.8%, from $2.60B to $2.70B. Over 3 years (FY 2022 to FY 2025), Established Pharmaceuticals — Goodwill, non-deductible shows relatively stable performance with a -0.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase suggests recent acquisitions at a premium, while a decrease may indicate impairment charges or the write-down of asset values. High levels relative to segment equity may signal future risk of impairment if the segment's growth prospects decline.
Detailed definition
This metric represents the portion of goodwill associated with the Established Pharmaceuticals segment that is not tax-d...
Peer comparison
Peers in the pharmaceutical and medical device sectors typically report goodwill by segment; non-deductible portions are common in large-scale M&A activity and are compared against total segment assets to assess balance sheet health.
abt_segment_established_pharmaceuticals_goodwill_non_deductibleHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 2.9B | 2.9B | 2.8B | 2.8B | 2.7B | 2.6B | 2.7B | 2.7B | 2.7B | 2.6B | 2.7B | 2.7B | 2.6B | 2.7B | 2.6B | 2.6B | 2.7B | 2.7B | 2.7B | 2.7B |
| QoQ Change | — | +0.0% | -3.4% | +0.0% | -3.6% | -3.7% | +3.8% | +0.0% | +0.0% | -3.7% | +3.8% | +0.0% | -3.7% | +3.8% | -3.7% | +0.0% | +3.8% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | -6.9% | -10.3% | -3.6% | -3.6% | +0.0% | +0.0% | +0.0% | +0.0% | -3.7% | +3.8% | -3.7% | -3.7% | +3.8% | +0.0% | +3.8% | +3.8% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Abbott's established pharmaceuticals — goodwill, non-deductible?
- Abbott (ABT) reported established pharmaceuticals — goodwill, non-deductible of $2.70B in Q1 2026.
- How has Abbott's established pharmaceuticals — goodwill, non-deductible changed year-over-year?
- Abbott's established pharmaceuticals — goodwill, non-deductible increased by 3.8% year-over-year, from $2.60B to $2.70B.
- What is the long-term trend for Abbott's established pharmaceuticals — goodwill, non-deductible?
- Over 3 years (2022 to 2025), Abbott's established pharmaceuticals — goodwill, non-deductible has grown at a -0.3% compound annual growth rate (CAGR), from $10.80B to $10.70B.
- What does established pharmaceuticals — goodwill, non-deductible mean?
- The amount of non-tax-deductible goodwill allocated to the Established Pharmaceuticals business segment.